Atlas Trials

Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease

Clinical trial NCT00852787 · UNKNOWN

Trial details

NCT number
NCT00852787
Sponsor
National Institute on Aging (NIA)
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionHemodialysis
Start date
2009-04-01
Primary completion
2012-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.